Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $4,345,000 | reported | |
| FY 2024 | 2024-12-31 | $6,770,000 | reported | |
| FY 2023 | 2023-12-31 | $44,384,000 | reported | |
| FY 2022 | 2022-12-31 | $122,647,000 | reported | |
| FY 2021 | 2021-12-31 | $79,042,000 | reported | |
| FY 2020 | 2020-12-31 | $14,514,000 | reported | |
| FY 2019 | 2019-12-31 | $9,876,000 | reported | |
| FY 2018 | 2018-12-31 | $13,126,000 | reported | |
| FY 2017 | 2017-12-31 | $9,867,000 | reported | |
| FY 2016 | 2016-12-31 | $21,014,000 | reported | |
| FY 2015 | 2015-12-31 | $20,604,000 | reported | |
| FY 2014 | 2014-12-31 | $22,070,000 | reported |
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR
Twelve months to Jun 30, 2026 · derived
ProPhase Labs, Inc. is the 181st largest of the 566 covered companies the SEC files under this code, by revenue. SIC 2834
Latest filing Aug 19, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $0.00 | $0.00 | — | 41.88M sh | +132.1% | — |
| FY2023 | $0.00 | $588.00K | $588.00K | — |
| 18.05M sh |
| +5.0% |
| — |
| FY2022 | $9.35M | $2.15M | $11.51M | $0.30 | 17.18M sh | +11.0% | 46.7% |
| FY2021 | $4.55M | $917.00K | $5.46M | $0.30 | 15.49M sh | +2.2% | — |
| FY2019 | $5.82M | — | $5.82M | — | 11.58M sh | +0.2% | — |
2 managers · Quarter ended Jun 30, 2026All holders ›
0No reported open-market purchases or sales in the last 12 months.